FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2026
Back to search
Official data from USPTO
DELFRANA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/30/2026
Trademark type
Word
Nice classes
5
Filing date
07/09/2024
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CH
Examiner
WELLS, KELLEY L
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.
Publications
History of USPTO decisions and trademark events.
31 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/26/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/11/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/10/2026
PUBO
PUBLISHED FOR OPPOSITION
02/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2026
RFNT
REFUSAL PROCESSED BY IB
08/29/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/12/2025
RFRR
REFUSAL PROCESSED BY MPU
08/12/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/12/2025
CNRT
NON-FINAL ACTION WRITTEN
08/11/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/19/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/22/2024
CNRT
NON-FINAL ACTION WRITTEN
12/21/2024
DOCK
ASSIGNED TO EXAMINER
12/21/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/19/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/12/2024
Continuous trademark protection
Get notified about every new filing that threatens DELFRANA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.